Hollywood A-lister Margot Robbie got married to husband Tom Ackerley in 2016, three years after the couple initially began ...

(Reuters) -Telehealth company Ro has enlisted former tennis player Serena Williams as a celebrity patient ambassador for its weight-loss treatments, it said on Thursday. She will star in a national ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage study, but that was less than previous trial results for Novo Nordisk's ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.

Eli Lilly (NYSE:LLY) is set to release its earnings on Thursday, August 7, 2025. In the past, Eli Lilly’s stock has displayed a pattern of negative one-day returns following earnings announcements.

Eli Lilly is investing up to $4 billion in the Bristol project and Wisconsin plans to provide up to $100 million in performance-based tax credits.

Lilly plans to sell its production site in Branchburg, New Jersey, as part of a broader production overhaul at the company, a spokesperson confirmed.

With the next generation of drugs in development amidst an ever-changing environment, here’s what we think of Lilly stock.

Love, Rosie, the beloved book-to-film adaptation starring Lily Collins and Sam Claflin is now streaming for free. Just make sure you have tissues!

Eli Lilly’s blockbuster diabetes drug Mounjaro matched the ability of an older treatment to prevent major heart complications in a large trial.